NEW YORK, June 11 - British structural proteomics company Astex Technology has joined the Global Phasing consortium, giving Astex early access to Global Phasing's software for modeling protein structure using x-ray crystallography, the companies said Monday.

Astex, based in Cambridge, UK, joins several undisclosed pharmaceutical companies in the consortium. In addition to early access to software, membership in the consortium allows Astex scientists to consult with Global Phasing software developers. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.